Follow the people · Insider
Roberto Wandenkolk Vieira
Roberto Wandenkolk Vieira files insider transactions with the SEC as a president, oncology of Corcept Therapeutics (CORT). We hold 1 disclosed purchase or sale filed since 3 September 2026, 1 of them in the last 90 days.
- Files forCORT
- Disclosed buys and sells1 in all, 1 in the last 90 days
- Last disclosure3 September 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 1 September 2026 — 2 September 2026President, Oncology · Corcept Therapeutics (CORT)12 Form 4 lines · source: SEC Form 4
Everything they disclosed
12 entries, newest first — one per disclosure report, one per Form 4 line- was granted 138 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 5,621 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 1,225 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- exercised options over 58,333 shares of Corcept Therapeutics (a derivative holding)SEC Form 43 September 2026Stock option (right to buy) · traded 2 September 2026 · filed 3 September 2026
- was granted 138 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 1 September 2026 · filed 3 September 2026
- had shares withheld for tax on 102 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- exercised options over 58,333 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 23,600 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 23,770 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 1,537 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 974 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
- ▼ sold on the open market 1,606 shares of Corcept TherapeuticsSEC Form 43 September 2026Common Stock · traded 2 September 2026 · filed 3 September 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.